November 15, 2023
For more than 50 years, the conventional wisdom in the field of cocaine self-administration research has been that people take cocaine based on the theory of the drug providing positive reinforcement to the user. New research out of UC shows that a pharmacological equation disproves that concept and could spark a major shift in that field of research.
September 21, 2023
Research from the University of Cincinnati looks at the molecular impact of psychological loss
October 2, 2020
A research center devoted to the science of addiction and determined to make a national impact has launched at the University of Cincinnati College of Medicine.
April 29, 2021
UC research found that some water bottles labeled BPA-free actually contained traces of the chemical and that multiple cycles through the dishwasher was the most effective at removing BPA.
April 11, 2023
The University of Cincinnati's Atsuo Sasaki, PhD, is leading a multidisciplinary team that received National Institutes of Health funding to learn more about how an enzyme that was previously overlooked helps regulate lysosome and cellular function.
February 7, 2023
The National Cancer Institute (NCI) has announced an intent to fund research from the University of Cincinnati’s Andrew Waters, PhD, to better understand how to overcome treatment resistance and develop better treatments for KRAS-mutated pancreatic cancer.
August 12, 2021
Spend your summer at UC learning how neuroscience reserach is conducted
April 12, 2022
The University of Cincinnati's Kyle Wang, MD, is the site principal investigator for the Trident trial, studying the effectiveness of earlier electrical treatment through Optune devices to treat glioblastomas.
November 7, 2022
The University of Cincinnati is part of a multimillion-dollar grant from the National Heart, Lung, and Blood Institute to study a strategy to prevent stroke in patients with atrial fibrillation. The trial will incorporate the use of an app on Apple Watch to monitor an irregular heartbeat to reduce patients’ reliance on blood-thinning medication.
October 20, 2022
New research out of the University of Cincinnati shows that a course of a hepatitis B vaccine provides complete protection for people with HIV. The UC research shows that a three-dose course of the hepatitis B vaccine HEPLISAV-B provides complete protection for people living with HIV who have never been vaccinated against or exposed to the hepatitis B virus (HBV).